This notion is consistent with the finding that a relatively low concentration of Aβ is able to up-regulate Wnt5a and Fz5 (Fig. 3), suggesting that Wnt5a signaling is a potential target for slowing or blocking early AD pathogenesis. This evidence concerns the gene WNT5A and Alzheimer disease.